目的观察低分子肝素钙联合尿激酶在脑血栓颈动脉斑块治疗中的效果。方法 46例脑血栓患者,随机分为对照组和观察组,各23例,对照组患者采用尿激酶治疗,观察组患者采用低分子肝素钙与尿激酶联合治疗,治疗后对两组治疗总有效率及不良反应等进行统计。结果对照组治疗总有效率为65.2%,观察组治疗总有效率为87.0%,组间对比差异有统计学意义(P<0.05)。两组不良反应发生情况比较,差异无统计学意义(P>0.05)。结论在脑血栓颈动脉斑块临床治疗中,采用低分子肝素钙联合尿激酶溶栓临床效果显著,预后情况良好,值得临床推广和使用。 Objective To observe the effect of low molecular weight heparin combined with urokinase in the treatment of cerebral thrombosis carotid plaque. Methods 46 patients with cerebral thrombosis were randomly divided into control group and observation group, 23 cases in each group. The control group was treated with urokinase. The observation group was treated with low molecular weight heparin and urokinase. After treatment, Efficiency and adverse reactions such as statistics. Results The total effective rate of the control group was 65.2%, the total effective rate of the observation group was 87.0%, the difference between the two groups was statistically significant (P <0.05). Adverse reactions between the two groups, the difference was not statistically significant (P> 0.05). Conclusion In the clinical treatment of cerebral thrombosis carotid plaque, low molecular weight heparin combined with urokinase thrombolytic therapy has significant clinical effect and good prognosis, which is worthy of clinical promotion and use.